BRAF and thyroid gland undifferentiated (anaplastic) carcinoma: Subbiah Subbiah V V Kreitman Kreitman RJ RJ Wainberg Wainberg ZA ZA Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600–mutant anaplastic thyroid cancer Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600–mutant anaplastic thyroid cancer J Clin Oncol J Clin Oncol 2017 2017 10.1200/jco.2017.73.6785 10.1200/jco.2017.73.6785 supplied-pmid 29072975?